Michael a rejoint Nanosonics en qualité de PDG et de président en octobre 2013. Il a été administrateur non exécutif du conseil d’administration de juillet 2012 à octobre 2013. Michael a plus de 26 ans d’expérience commerciale internationale sur le marché de la santé et a occupé des rôles au niveau régional et mondial dans les industries des dispositifs médicaux et pharmaceutiques. Avant de rejoindre Nanosonics, il était vice-président senior du marketing mondial pour la grande entreprise de matériel médical Cochlear Ltd, un poste qu’il a occupé pendant plus de 10 ans.

Steven joined Nanosonics as Senior Vice President, Design and Development, in September 2016 and was appointed to the role of CTO in February 2018. He has over 21 years’ experience leading the development of medical devices. Prior to Nanosonics, Steven held a range of senior executive roles with ResMed, including VP of Technology and VP of Product Development. He is an inventor of almost 300 granted and pending patents and is an Adjunct Professor of Engineering at The University of Sydney.

McGregor joined Nanosonics in April 2011. He is responsible for the overall financial management of the Company and also serves as the Company Secretary. McGregor has more than 23 years’ business experience in a number of senior roles in the medical device and healthcare industries located in Australia and the United States, and previously worked for Coopers & Lybrand (now PwC) in Australia and Europe.

Matthew joined Nanosonics in April 2022. He has over 20 years of experience in strategic marketing and product management in medical device, high technology and consulting fields across the full product development cycle. Prior to Nanosonics, Matthew held a range of strategic executive roles including Global Director of Portfolio Strategy & Planning at Cochlear, R&D management at ResMed and Founder-CEO of an enterprise SaaS software startup.

Rod a rejoint Nanosonics en avril 2019. Il est cadre opérationnel international et dispose de plus de 20 ans d’expérience, ayant occupé des postes clés dans des entreprises telles que Cochlear et GM Holden. Au cours de ses 13 années chez Cochlear, Rod a occupé des postes tels que responsable mondial de la fabrication et président du groupe stratégique d’excellence opérationnelle. Chez GM Holden, Rod a occupé des postes de direction dans le domaine des opérations et du support clients mondial. Rod est également un universitaire émérite qui a occupé pendant plus de 12 ans des postes de professeur adjoint à la MGSM, à l’AGSM et à l’école de commerce de l’Université de Sydney.

Matt joined Nanosonics in August 2017 and was appointed to the Executive Team in October 2021. Matt is responsible for all legal matters across the Nanosonics Group and supports the Company Secretary on corporate governance matters. Prior to joining Nanosonics, Matt held a variety of senior legal roles in Australia and abroad with a focus on technology and healthcare. Immediately prior to joining Nanosonics, Matt served as General Counsel for an international software business based in London. Matt is a member of the Australian Institute of Company Directors, and the Governance Institute of Australia.

Jodi joined Nanosonics in April 2020. Jodi is an experienced human resources professional who has contributed to strategy, culture and business transformation at an executive level in the finance, telco and IT industries. Most recently, Jodi was Head of Human Resources with the Eclipx Group. She has also led international human resource functions as HR Director for Samsung and Head of Human Resources, Asia Pacific at Orange Business Services.

Ronan joined Nanosonics in September 2019 and is responsible for Nanosonics’ continued expansion across Europe and the Middle East. He has more than 20 years’ experience in infection prevention through senior sales, management and business development roles with Advanced Sterilization Products and Wassenburg Medical, a global leader in endoscope reprocessing. Most recently, Ronan was the Vice President of Global Sales and a Board member at Wassenburg Medical, where he had also served as Managing Director for Ireland and Director of Business Development for EMEA.

Ken joined Nanosonics in September 2017 as Regional President for the United States, Canada and Latin America. He has more than 20 years’ experience in the healthcare, medical devices and consumer products industries. Most recently Ken was the President for Amoena GmbH and prior to that he held general management roles at BSN Medical, Medicom, Energizer and Pfizer.

David joined Nanosonics in February 2019. David has more than 25 years of executive leadership, international business development, and strategy experience. David was Chief Executive Officer and Managing Director at the Monash IVF Group, and prior to that he was an Executive at Cochlear Limited, where he was the Chief Strategy Officer, and the President of Bone Anchored Solutions. Prior to joining Cochlear Limited, David worked at Accenture in their Strategy practice.

Katsumi a rejoint Nanosonics en avril 2016 en tant que directeur national par intérim pour le Japon, et a joué un rôle important dans l’établissement et la croissance de l’activité japonaise pendant cette période. Nanosonics Japan K.K. a été créée en janvier 2019 et Katsumi a été nommé président de Nanosonics Japan K.K en septembre 2019. Katsumi possède plus de 25 ans d’expérience dans le développement et la gestion d’entreprises et d’investissements entre l’Australie et le Japon dans le secteur des sciences de la vie. Il a été membre du Conseil d’administration et a occupé des postes de direction dans de grandes entreprises internationales en Australie et au Japon.

Gareth a rejoint Nanosonics en février 2020 pour soutenir les activités existantes en Europe, au Moyen-Orient et en Afrique. Gareth apporte avec lui une grande expérience spécialisée dans le domaine de la décontamination des dispositifs médicaux invasifs réutilisables. Gareth a commencé sa carrière chez Wassenburg Medical Ireland, experts en solutions de retraitement des endoscopes et de prévention des infections, avant de rejoindre Cantel Medical Canada. Tout en soutenant leur expansion en Amérique du Nord, il a travaillé sur les produits de prévention des infections et des procédures utilisées pour l’endoscopie et les produits stériles pour les services centraux de stérilisation.

Ms. Klatt joined the Nanosonics team in October 2021. She has more than 20 years of national and international commercial experience in the healthcare market, having held local, regional and global roles in medical device industry. Before joining Nanosonics, she was working in several leadership and board roles in sales and marketing for companies like Medtronic, Hill-Rom, Baxter and Spacelabs. In addition, Ms. Klatt has been developing prospective executives in the context of training and coaching for many years. For her second degree in Marketing she was honored with the “German Study Award 2010”.